Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXJYB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,585
Award facts
- Contract value 100% obligated
- $14,584.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml) under a firm fixed-price contract with a ceiling value of $14,584.62. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain, delivering diabetes medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Zepbound, a tirzepatide-based weight management medication, reflects the company's ongoing role as a key supplier of brand-name pharmaceuticals to federal healthcare programs, particularly through the DLA's strategic pharmaceutical procurement initiatives.
Quick answers
Who was awarded contract SPE2DB25FXJYB?
SPE2DB25FXJYB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FXJYB worth?
The government has obligated $14,585 on SPE2DB25FXJYB.
Is contract SPE2DB25FXJYB an order under another contract?
Yes. SPE2DB25FXJYB is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXJYB competed?
The extent of competition for SPE2DB25FXJYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award